These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38484445)

  • 1. Advances in self-assembled nanotechnology in tumor therapy.
    Kuang Y; Li Z; Chen H; Wang X; Wen Y; Chen J
    Colloids Surf B Biointerfaces; 2024 May; 237():113838. PubMed ID: 38484445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier-Free Nanomedicine for Cancer Immunotherapy.
    Fu Y; Bian X; Li P; Huang Y; Li C
    J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxanes prodrug-based nanomedicines for cancer therapy.
    Sun L; Zhao P; Chen M; Leng J; Luan Y; Du B; Yang J; Yang Y; Rong R
    J Control Release; 2022 Aug; 348():672-691. PubMed ID: 35691501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
    Raza F; Zafar H; You X; Khan A; Wu J; Ge L
    J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Phe-Phe Motif for Peptide Self-Assembly in Nanomedicine.
    Marchesan S; Vargiu AV; Styan KE
    Molecules; 2015 Nov; 20(11):19775-88. PubMed ID: 26540034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
    Guo L; Yang J; Wang H; Yi Y
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging Bio-Nano Science and Cancer Nanomedicine.
    Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
    ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled polymeric vesicles: Focus on polymersomes in cancer treatment.
    Araste F; Aliabadi A; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    J Control Release; 2021 Feb; 330():502-528. PubMed ID: 33358973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
    Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology: Revolutionizing the Science of Drug Delivery.
    Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
    Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging.
    Ouyang J; Xie A; Zhou J; Liu R; Wang L; Liu H; Kong N; Tao W
    Chem Soc Rev; 2022 Jun; 51(12):4996-5041. PubMed ID: 35616098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation targeted nanomedicines: Patents and applications in cancer therapy.
    Praveen TK; Gangadharappa HV; Abu Lila AS; Moin A; Mehmood K; Krishna KL; Hussain T; Alafnan A; Shakil S; Rizvi SMD
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):645-663. PubMed ID: 35405339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
    Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
    Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.